Ratings China Pacific Insurance (Group) Co., Ltd. Hong Kong S.E.

Equities

2601

CNE1000009Q7

Market Closed - Hong Kong S.E. 04:09:02 2024-07-04 am EDT 5-day change 1st Jan Change
19.96 HKD -0.45% Intraday chart for China Pacific Insurance (Group) Co., Ltd. +1.63% +26.65%

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • Its low valuation, with P/E ratio at 8.78 and 8.22 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
  • The company appears to be poorly valued given its net asset value.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • The opinion of analysts covering the stock has improved over the past four months.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Life & Health Insurance

1st Jan change Capi. Investor Rating ESG Refinitiv
+26.65% 34.2B -
+9.73% 75.31B
B-
+7.99% 50.62B
B
+6.09% 49.89B
B+
+24.93% 48.03B
B+
+14.31% 42.57B
B+
+25.36% 39.64B
B
-1.63% 28.76B
B
-8.91% 27.33B
B-
+34.43% 27.68B
A
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 601601 Stock
  4. 2601 Stock
  5. Ratings China Pacific Insurance (Group) Co., Ltd.